Vaniqa
Indicated to support the reduction of unwanted facial hair growth in women.
- Categories
- Women's Health · Skin Care
- Active ingredient
- Eflornithine
- Route
- Cutaneous use
- Form
- Cream
- Strengths
- 13.9%
You will receive a quality generic equivalent, depending on stock.
Prescription rules on Vaniqa vary by country.
Vaniqa details
- Condition
- Hirsutism
- Therapeutic class
- Ornithine Decarboxylase Inhibitor
- Pharmacological class
- Ornithine Decarboxylase Inhibitor
- Contraindications
- hypersensitivity to eflornithine
- Precautions and warnings
- avoid contact with eyes or mucous membranes; discontinue if irritation occurs
- Minor side effects
- skin irritation; stinging sensation; burning sensation
- Moderate side effects
- dry skin; acne; ingrown hair
- Serious side effects
- anaphylaxis, requires immediate medical attention
- Dosage forms
- Cream
- Administration route
- Cutaneous use
- Patient summary
- indicated to support the reduction of unwanted facial hair growth in women.
- Supply category
- Pharmacist-supplied medicine; local rules apply
- Originator
- Almirall
- Onset Time
- 4–8 weeks
- Duration
- Continuous use
- Storage instructions
- Store below 25°C. Do not freeze.
- Age restrictions
- Not indicated for use in paediatric patients.
Mechanism of action
It works by inhibiting the enzyme ornithine decarboxylase in the hair follicle, which is required for hair cell division, thereby slowing the rate of hair growth.
Pregnancy and breastfeeding
Pregnancy: Not recommended unless clearly necessary. Breastfeeding: Use with caution as it is unknown if it passes into breast milk.
What you will receive
Vaniqa is the originator brand name, made by Almirall. We use it here to identify the medicine only; we are not affiliated with Almirall and do not ship the original Vaniqa.
- You receive a generic equivalent: the same active ingredient (Eflornithine) at the same dose, mostly recognised Indian branded generics from vetted manufacturers.
- The exact brand supplied depends on what is in stock at the dispatching warehouse.
- A regulated generic matches the original ingredient for ingredient by legal standard.
Registration in Singapore and Malaysia
- Singapore
- Malaysia
About Vaniqa
Vaniqa is a specialized treatment for hirsutism, a condition characterized by unwanted facial hair growth in women. The cream contains the active ingredient eflornithine, which functions by inhibiting enzymes in hair follicles to slow down growth. This targeted topical solution is supplied in a tube of 13.9% strength.
Buying Vaniqa online
Vaniqa is registered across 14 markets including Thailand, Malaysia and the Philippines, with availability also in Indonesia, Taiwan and South Korea. Residents and expats who find it difficult to locate consistent stock in local retail shops often turn to ordering online, making this one of the most ordered items across the region for those looking for a reliable, accessible solution for facial hair management.